Source: Annual Congress 2003 - Lung cancer: clinical and biological presentation
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
G. V. Nikolaev, V. K. Kossenok, G. Massard, X. Ducrocq, J. Lemaitre, R. Kessler, E. Quoix, J. M. Wihlm (Strasbourg, France). Contribution of tumor markers to pretreatment staging of operable lung cancer. Eur Respir J 2003; 22: Suppl. 45, 2278

Member's Comments

No comment yet.

Related content which might interest you: Comparison of clinic and pathological staging in non-small cell lung cancer Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010 Staging of lung cancer Source: Eur Respir Mon; 2009: 44: 150–168 Year: 2009 Extra-mediastinal FDG-PET hot-spots in a study of mediastinal staging of non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 458s Year: 2004 Staging and restaging in the era of multimodality treatment Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer Year: 2006 Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012 Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006 Comparison of the new and current TNM staging system in bronchoplastic resection for non-small cell lung cancer Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010 An algorithm for lung cancer staging Source: School Course 2014- Endoscopic ultrasound in the diagnosing and staging of lung cancer Year: 2014 Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease? Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018 Year: 2019 Staging of non-small-cell lung cancer with FDG-PET/CT: Is there a correlation of morphologic tumor characteristics and metabolic activity? Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life Year: 2012 Impact of neoadjuvant therapy on tumor resectability and survival of patients with locally advanced non-small cell lung cancer Source: Annual Congress 2011 - General thoracic surgery II Year: 2011 Intrathoracic lymph node staging of potentially resectable non-small cell lung cancer - The role of PET-CT Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Features of N-staging in left-sided non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 719s Year: 2006 Surgical multimodality treatment for stage III non-small cell lung cancer (NSCLC) Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer Year: 2006 Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer Source: Breathe, 14 (4) 342; 10.1183/20734735.027118 Year: 2018 Integrated FDG-PET/CT for improved T and N staging of non-small-cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 784s Year: 2006 Age and stage at presentation in lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 Prognostic factors for unresectable non-small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 270s Year: 2002 Extrathoracic 18-FDG-PET uptakes in non small cell lung cancer (NSCLC) preoperative staging Source: Eur Respir J 2007; 30: Suppl. 51, 430s Year: 2007